Evaluation of immune cell subsets of cancer patients treated with Avelumab, a fully human IgG1 anti-PD-L1 MAb capable of mediating ADCC of human tumor cells

Detalles Bibliográficos
Autores principales: Lepone, Lauren, Donahue, Renee, Grenga, Italia, Jochems, Caroline, Tsang, Kwong-Yok, Metenou, Simon, Richards, Jacob, Heery, Christopher R, Madan, Ravi, Gulley, James L, Schlom, Jeffrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649381/
http://dx.doi.org/10.1186/2051-1426-3-S2-P254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649381/
http://dx.doi.org/10.1186/2051-1426-3-S2-P254

Ejemplares similares